These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 3660982)
21. Strain- and Dose-Dependent Reduction of Jennes M; De Craeye S; Devriendt B; Dierick K; Dorny P; Cox E Front Cell Infect Microbiol; 2017; 7():232. PubMed ID: 28642841 [No Abstract] [Full Text] [Related]
22. Brain-tissue cysts in rats infected with the RH strain of Toxoplasma gondii. Lecomte V; Chumpitazi BF; Pasquier B; Ambroise-Thomas P; Santoro F Parasitol Res; 1992; 78(3):267-9. PubMed ID: 1589437 [TBL] [Abstract][Full Text] [Related]
23. Protective effects of immunization with a recombinant cyst antigen in mouse models of infection with Toxoplasma gondii tissue cysts. Parmley S; Slifer T; Araujo F J Infect Dis; 2002 Feb; 185 Suppl 1():S90-5. PubMed ID: 11865445 [TBL] [Abstract][Full Text] [Related]
24. A recombinant pseudorabies virus expressing TgSAG1 protects against challenge with the virulent Toxoplasma gondii RH strain and pseudorabies in BALB/c mice. Liu Q; Gao S; Jiang L; Shang L; Men J; Wang Z; Zhai Y; Xia Z; Hu R; Zhang X; Zhu XQ Microbes Infect; 2008 Oct; 10(12-13):1355-62. PubMed ID: 18761418 [TBL] [Abstract][Full Text] [Related]
25. Long term maintenance of Toxoplasma gondii (Rh strain) in Vero cell line and use of harvested antigens for immunodiagnosis. Suresh K; Mak JW; Yong HS Southeast Asian J Trop Med Public Health; 1991 Dec; 22 Suppl():124-8. PubMed ID: 1822869 [TBL] [Abstract][Full Text] [Related]
26. Role of L3T4+ and Lyt-2+ T cell subsets in protective immune responses of mice against infection with a low or high virulent strain of Toxoplasma gondii. Nagasawa H; Manabe T; Maekawa Y; Oka M; Himeno K Microbiol Immunol; 1991; 35(3):215-22. PubMed ID: 1870439 [TBL] [Abstract][Full Text] [Related]
27. Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of toxoplasma gondii induces immune response and protection against infection in mice. Caetano BC; Bruña-Romero O; Fux B; Mendes EA; Penido ML; Gazzinelli RT Hum Gene Ther; 2006 Apr; 17(4):415-26. PubMed ID: 16610929 [TBL] [Abstract][Full Text] [Related]
28. Experimental infection of budgerigars (Melopsittacus undulatus) with a low virulent K21 strain of Toxoplasma gondii. Kajerová V; Literák I; Bártová E; Sedlák K Vet Parasitol; 2003 Oct; 116(4):297-304. PubMed ID: 14580800 [TBL] [Abstract][Full Text] [Related]
29. Toxoplasma gondii: Protective immunity induced by a DNA vaccine expressing GRA1 and MIC3 against toxoplasmosis in BALB/c mice. Gong P; Cao L; Guo Y; Dong H; Yuan S; Yao X; Ren W; Yao L; Xu Z; Sun Q; Zhang X Exp Parasitol; 2016 Jul; 166():131-6. PubMed ID: 27059254 [TBL] [Abstract][Full Text] [Related]
30. DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice. Chen J; Huang SY; Zhou DH; Li ZY; Petersen E; Song HQ; Zhu XQ Vaccine; 2013 Dec; 31(52):6225-31. PubMed ID: 24183979 [TBL] [Abstract][Full Text] [Related]
31. Excretory-secretory antigens: a suitable candidate for immunization against ocular toxoplasmosis in a murine model. Norouzpour Deilami K; Daryani A; Ahmadpour E; Sharif M; Dadimoghaddam Y; Sarvi S; Alizadeh A Comp Immunol Microbiol Infect Dis; 2014 Dec; 37(5-6):369-74. PubMed ID: 25467037 [TBL] [Abstract][Full Text] [Related]
32. [Immune response in mice induced by complex gene vaccine pcSAG1-ROP5 of Toxoplasma gondii]. Zhao HG; Fan ZG; Huang FY; Huang YH; Zhou SL; Lin YY; Tan GH Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2013 Feb; 31(1):1-5. PubMed ID: 24812827 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis. Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690 [TBL] [Abstract][Full Text] [Related]
34. Protection induced by virus-like particles containing Toxoplasma gondii microneme protein 8 against highly virulent RH strain of Toxoplasma gondii infection. Lee SH; Kim AR; Lee DH; Rubino I; Choi HJ; Quan FS PLoS One; 2017; 12(4):e0175644. PubMed ID: 28406951 [TBL] [Abstract][Full Text] [Related]
35. Vaccination of mice with Neospora caninum: response to oral challenge with Toxoplasma gondii oocysts. Lindsay DS; Lenz SD; Dykstra CC; Blagburn BL; Dubey JP J Parasitol; 1998 Apr; 84(2):311-5. PubMed ID: 9576504 [TBL] [Abstract][Full Text] [Related]
36. Murine immune responses to recombinant Toxoplasma gondii antigens. Parker SJ; Smith FM; Johnson AM J Parasitol; 1991 Jun; 77(3):402-9. PubMed ID: 2040952 [TBL] [Abstract][Full Text] [Related]
37. Epitope analysis and protection by a ROP19 DNA vaccine against Toxoplasma gondii. Zhou J; Wang L; Lu G; Zhou A; Zhu M; Li Q; Wang Z; Arken M; Wang A; He S Parasite; 2016; 23():17. PubMed ID: 27055564 [TBL] [Abstract][Full Text] [Related]
38. Toxoplasma gondii: detection of MIC10 antigen in sera of experimentally infected mice. Dautu G; Ueno A; Miranda A; Mwanyumba S; Munyaka B; Carmen G; Kariya T; Omata Y; Saito A; Xuan X; Igarashi M Exp Parasitol; 2008 Mar; 118(3):362-71. PubMed ID: 17976597 [TBL] [Abstract][Full Text] [Related]
39. Vaccination against murine toxoplasmosis using recombinant Toxoplasma gondii SAG3 antigen alone or in combination with Quil A. Lee YH; Shin DW; Lee JH; Nam HW; Ahn MH Yonsei Med J; 2007 Jun; 48(3):396-404. PubMed ID: 17594146 [TBL] [Abstract][Full Text] [Related]
40. Infection and immunity with the RH strain of Toxoplasma gondii in rats and mice. Dubey JP; Shen SK; Kwok OC; Frenkel JK J Parasitol; 1999 Aug; 85(4):657-62. PubMed ID: 10461945 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]